STOCK TITAN

ViewRay® to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

ViewRay, Inc. (NASDAQ: VRAY) announced participation in three virtual investor conferences scheduled for September 2020. The first event is the Cantor Virtual Global Healthcare Conference on September 16, followed by the Morgan Stanley 18th Annual Global Healthcare Conference on September 18 at 11:00 am ET. Finally, ViewRay will attend the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 23 at 2:30 pm ET. Replays of the fireside chats will be available for 14 days post-presentation.

Positive
  • None.
Negative
  • None.

CLEVELAND, Sept. 4, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the Company will participate in three upcoming virtual investor conferences.

Event:            

Cantor Virtual Global Healthcare Conference

Format:      

Virtual 1x1 Meetings

Date:               

Wednesday, September 16, 2020



Event:             

Morgan Stanley 18th Annual Global Healthcare Conference

Format:            

Virtual Fireside Chat & 1x1 Meetings

Date:            

Friday, September 18, 2020

Time:                  

11:00 am ET

Link:         

http://investors.viewray.com/events-and-presentations/upcoming-events



Event:           

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Format:           

Virtual Fireside Chat & 1x1 Meetings

Date:                   

Wednesday, September 23, 2020

Time:              

2:30 pm ET

Link:                  

https://wsw.com/webcast/oppenheimer5/vray/2755458  

A replay of the fireside chats will be available for 14 days after the date of the presentation at http://investors.viewray.com/events-and-presentations/upcoming-events.

About ViewRay

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/viewray-to-participate-in-upcoming-investor-conferences-301124365.html

SOURCE ViewRay, Inc.

FAQ

What events will ViewRay participate in September 2020?

ViewRay will participate in the Cantor Virtual Global Healthcare Conference on September 16, Morgan Stanley 18th Annual Global Healthcare Conference on September 18, and Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 23.

What is the schedule for ViewRay's investor conferences?

ViewRay's conferences are scheduled as follows: Cantor Virtual Global Healthcare Conference on September 16, Morgan Stanley Conference on September 18 at 11:00 am ET, and Oppenheimer Summit on September 23 at 2:30 pm ET.

How can I access replays of ViewRay's fireside chats?

Replays of ViewRay's fireside chats will be available for 14 days after the presentations, accessible at their official events page.

What is the link for ViewRay's upcoming events?

The link for ViewRay's upcoming events is http://investors.viewray.com/events-and-presentations/upcoming-events.

What product does ViewRay manufacture?

ViewRay designs and manufactures the MRIdian radiation therapy system, which utilizes high-definition MR imaging for advanced radiation oncology.

ViewRay Inc.

NASDAQ:VRAY

VRAY Rankings

VRAY Latest News

VRAY Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Oakwood Village